Most Active InvestorsFind investorsPricing
Start for free
Start for free
Helicase Venture logo

Helicase Venture

North America, Massachusetts, United States, Boston

Description

Helicase Venture is an investment firm focused on healthcare.

Investor Profile

Helicase Venture has backed more than 9 startups, with 0 new investments in the last 12 months alone. The firm has led 1 rounds, about 11% of its total and boasts 3 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series Unknown, Series A, Series B rounds (top funding stages).
  • Majority of deals are located in United States, Taiwan, Austria.
  • Strong thematic focus on Biotechnology, Health Care, Pharmaceutical.

Stage Focus

  • Series Unknown (33%)
  • Series A (22%)
  • Series B (22%)
  • Seed (11%)
  • Series C (11%)

Country Focus

  • United States (78%)
  • Taiwan (11%)
  • Austria (11%)

Industry Focus

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Therapeutics
  • Artificial Intelligence (Ai)
  • Biopharma
  • Life Science
  • Medical
  • Clinical Trials
  • Machine Learning
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Helicase Venture frequently co-invest with?

RBV Capital
RBV Capital
Europe, Zug, Switzerland, Zug
Co-Investments: 2
Sectoral Asset Management
Sectoral Asset Management
North America, Quebec, Canada, Montréal
Co-Investments: 2
Alexandria Venture Investments
Alexandria Venture Investments
North America, California, United States, Pasadena
Co-Investments: 1
Casdin Capital
Casdin Capital
North America, New York, United States, New York
Co-Investments: 2
Versant Ventures
Versant Ventures
North America, California, United States, Menlo Park
Co-Investments: 2
Hadean Ventures
Hadean Ventures
Europe, Oslo, Norway, Oslo
Co-Investments: 3
Perceptive Advisors
Perceptive Advisors
North America, New York, United States, New York
Co-Investments: 3
Brace Pharma
Brace Pharma
North America, Maryland, United States, Rockville
Co-Investments: 2
Adjuvant Capital
Adjuvant Capital
North America, New York, United States, New York
Co-Investments: 1
Mission BioCapital
Mission BioCapital
North America, Massachusetts, United States, Cambridge
Co-Investments: 2

Which angels does Helicase Venture often collaborate with?

AI
Andrew Izyumov
Europe, Cyprus
Shared Deals: 1
CG
Chris Garabedian
North America, Massachusetts, United States, Boston
Shared Deals: 1
JM
Jonathan Milner
North America, Massachusetts, United States, Cambridge
Shared Deals: 1

What are some of recent deals done by Helicase Venture?

Ribbon Biolabs

Vienna, Wien, Austria

Ribbon Biolabs defines new standards for molecular biology by applying innovative methods for DNA synthesis.

Biotechnology
Series AJan 31, 2022
Amount Raised: $20,212,909
Absci

Vancouver, Washington, United States

Absci is the drug & target discovery company harnessing deep learning AI & synthetic biology to expand the therapeutic potential of proteins

Artificial Intelligence (AI)BiopharmaBiotechnologyLife Science
Series UnknownMar 23, 2021
Amount Raised: $125,000,000
Pipeline Therapeutics

San Diego, California, United States

Pipeline Therapeutics is a developer of regenerative therapies designed to promote functional recovery of neurological diseases.

BiotechnologyHealth CarePharmaceuticalTherapeutics
Series CFeb 11, 2021
Amount Raised: $80,000,000
Totient

Cambridge, Massachusetts, United States

Totient is an AI-driven biotechnology company that leverages tertiary lymphoid structures.

Artificial Intelligence (AI)BiotechnologyLife ScienceMachine Learning
SeedSep 10, 2020
Amount Raised: $10,000,000
Pipeline Therapeutics

San Diego, California, United States

Pipeline Therapeutics is a developer of regenerative therapies designed to promote functional recovery of neurological diseases.

BiotechnologyHealth CarePharmaceuticalTherapeutics
Series BDec 18, 2019
Amount Raised: $32,000,000
Landos Biopharma

Blacksburg, Virginia, United States

Landos Biopharma is a developer of an oral first-in-class therapeutics designed to target autoimmune diseases.

BiopharmaBiotechnologyClinical TrialsHealth CarePharmaceuticalTherapeutics
Series BAug 13, 2019
Amount Raised: $60,000,000
X-Vax Technology

Jupiter, Florida, United States

X-VAX is a biotech company committed to developing vaccines against pathogens acquired by mucosal infection such as herpes.

BiotechnologyHealth CareMedical
Series AJul 23, 2019
Amount Raised: $56,000,000
Tangible Science

Redwood City, California, United States

Tangible Science is a developer of contact lenses designed to reduce lens discomfort in dry eye diseases.

BiotechnologyConsumer GoodsHealth CareMedical Device
Series UnknownJan 15, 2019
Amount Raised: $2,000,000
Medeon Biodesign

Taipei, T'ai-pei, Taiwan

Medeon Biodesign (TPEx: 6499) is a publicly traded company .

Series UnknownJan 1, 2019
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Most Active Investors Find InvestorsNewsletterPricing

Free tools

Pre-Money and Post-Money Valuation Calculator